FranΓ§aisπ See the interactive version (live chart) β
| Investment | Value today | Gain |
|---|---|---|
| 1 years ago (2025) | $1,229 | +23% |
| 3 years ago (2023) | $1,041 | +4% |
| 5 years ago (2021) | $908 | -9% |
| 10 years ago (2016) | $2,821 | +182% |
| since 2000 | $7,513 | +651% |
| Year | Year's return | $1,000 invested at year start β worth today |
|---|---|---|
| 2026 (YTD) | +14% | $1,137 (+14%) |
| 2025 | +8% | $1,229 (+23%) |
| 2024 | -22% | $959 (-4%) |
| 2023 | +8% | $1,041 (+4%) |
| 2022 | -42% | $602 (-40%) |
| 2021 | +51% | $908 (-9%) |
| 2020 | +64% | $1,485 (+48%) |
| 2019 | +35% | $2,004 (+100%) |
| 2018 | +3% | $2,072 (+107%) |
| 2017 | +44% | $2,977 (+198%) |
| 2016 | -5% | $2,821 (+182%) |
π See the analyst analysis of Charles River Laboratories β
$1000 invested in Charles River Laboratories 5 years ago would be worth $908 today, and $2,821 over 10 years (price return, excluding dividends).
Calendar-year returns β 2024: -22%. 2025: +8%. 2026: +14%. Full breakdown in the table above.
Over 10 years, Charles River Laboratories's average annual return (CAGR) is about 11% per year, and -2%/yr over 5 years.
Best year: 2020 (+64%). Worst year: 2022 (-42%).
It's proportional β just multiply. Over 5 years, $1,000 invested in Charles River Laboratories is worth $908, so $100 would be worth a tenth, $5,000 five times more, and $10,000 ten times more. Use the calculator at the top of the page for your exact amount and chosen year.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Past performance, no predictive value and not investment advice. Prices in $, excluding dividends. Data: Yahoo Finance.